Health
Newly identified biomarker could predict response to immune checkpoint inhibitors – News-Medical.net
A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI)…
A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy. This discovery, published today in the journal Nature Communications, is not only an important step forward in lung cancer treatment, but also has implications for other malignancies, according to lead author Fumito Ito, MD, PhD, FACS.
“Although ICIs revolutionized…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General19 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News21 hours agoNew FLC President has regional lens – Proctor
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?